Literature DB >> 26223805

Elevated body temperature is linked to fatigue in an Italian sample of relapsing-remitting multiple sclerosis patients.

V M Leavitt1, E De Meo2, G Riccitelli2, M A Rocca2,3, G Comi3, M Filippi2,3, J F Sumowski4.   

Abstract

Elevated body temperature was recently reported for the first time in patients with relapsing-remitting multiple sclerosis (RRMS) relative to healthy controls. In addition, warmer body temperature was associated with worse fatigue. These findings are highly novel, may indicate a novel pathophysiology for MS fatigue, and therefore warrant replication in a geographically separate sample. Here, we investigated body temperature and its association to fatigue in an Italian sample of 44 RRMS patients and 44 age- and sex-matched healthy controls. Consistent with our original report, we found elevated body temperature in the RRMS sample compared to healthy controls. Warmer body temperature was associated with worse fatigue, thereby supporting the notion of endogenous temperature elevations in patients with RRMS as a novel pathophysiological factor underlying fatigue. Our findings highlight a paradigm shift in our understanding of the effect of heat in RRMS, from exogenous (i.e., Uhthoff's phenomenon) to endogenous. Although randomized controlled trials of cooling treatments (i.e., aspirin, cooling garments) to reduce fatigue in RRMS have been successful, consideration of endogenously elevated body temperature as the underlying target will enhance our development of novel treatments.

Entities:  

Keywords:  Fatigue; Multiple sclerosis; Temperature

Mesh:

Year:  2015        PMID: 26223805     DOI: 10.1007/s00415-015-7863-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.

Authors:  D M Wingerchuk; E E Benarroch; P C O'Brien; B M Keegan; C F Lucchinetti; J H Noseworthy; B G Weinshenker; M Rodriguez
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

2.  The authors respond.

Authors:  Victoria M Leavitt; James F Sumowski
Journal:  Arch Phys Med Rehabil       Date:  2015-01-08       Impact factor: 3.966

3.  A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS).

Authors:  P Svanborg; M Asberg
Journal:  J Affect Disord       Date:  2001-05       Impact factor: 4.839

4.  Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?

Authors:  N Téllez; J Río; M Tintoré; C Nos; I Galán; X Montalban
Journal:  Mult Scler       Date:  2005-04       Impact factor: 6.312

5.  Fatigue in multiple sclerosis persists over time: a longitudinal study.

Authors:  N Téllez; J Río; M Tintoré; C Nos; I Galán; X Montalban
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

6.  Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study.

Authors:  Vahid Shaygannejad; Mohsen Janghorbani; Fereshteh Ashtari; Hasanali Zakeri
Journal:  Neurol Res       Date:  2012-09-12       Impact factor: 2.448

7.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir-Nash; A D Steinberg
Journal:  Arch Neurol       Date:  1989-10

Review 8.  Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Ole Köhler; Michael E Benros; Merete Nordentoft; Michael E Farkouh; Rupa L Iyengar; Ole Mors; Jesper Krogh
Journal:  JAMA Psychiatry       Date:  2014-12-01       Impact factor: 21.596

9.  Lateral ventricular cerebrospinal fluid diffusivity as a potential neuroimaging marker of brain temperature in multiple sclerosis: a hypothesis and implications.

Authors:  Khader M Hasan; John A Lincoln; Flavia M Nelson; Jerry S Wolinsky; Ponnada A Narayana
Journal:  Magn Reson Imaging       Date:  2014-12-05       Impact factor: 2.546

10.  A randomized controlled study of the acute and chronic effects of cooling therapy for MS.

Authors:  Steven R Schwid; Mary D Petrie; Ronald Murray; Jennifer Leitch; James Bowen; Alan Alquist; Richard Pelligrino; Adam Roberts; Judith Harper-Bennie; Maria Dawn Milan; Raul Guisado; Bernadette Luna; Leslie Montgomery; Richard Lamparter; Yu-Tsuan Ku; Hank Lee; Danielle Goldwater; Gary Cutter; Bruce Webbon
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

View more
  7 in total

1.  Acute Thermoregulatory and Cardiovascular Response to Submaximal Exercise in People With Multiple Sclerosis.

Authors:  Elisa Gervasoni; Rita Bertoni; Denise Anastasi; Claudio Solaro; Rachele Di Giovanni; Erica Grange; Hanns-Christian Gunga; Marco Rovaris; Davide Cattaneo; Martina Anna Maggioni; Giampiero Merati
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

Review 2.  Wearable biosensors to monitor disability in multiple sclerosis.

Authors:  Michael J Bradshaw; Samantha Farrow; Robert W Motl; Tanuja Chitnis
Journal:  Neurol Clin Pract       Date:  2017-08

Review 3.  Uhthoff`s phenomenon 125 years later - what do we know today?

Authors:  J A Opara; W Brola; A A Wylegala; E Wylegala
Journal:  J Med Life       Date:  2016 Jan-Mar

4.  Subjective Cognitive Fatigue and Autonomic Abnormalities in Multiple Sclerosis Patients.

Authors:  Carina Sander; Helmut Hildebrandt; Hans-Peter Schlake; Paul Eling; Katrin Hanken
Journal:  Front Neurol       Date:  2017-09-13       Impact factor: 4.003

5.  Diuretic-sensitive electroneutral Na+ movement and temperature effects on central axons.

Authors:  Meneka Kanagaratnam; Christopher Pendleton; Danilo Almeida Souza; Joseph Pettit; James Howells; Mark D Baker
Journal:  J Physiol       Date:  2017-03-22       Impact factor: 5.182

6.  The Seasonal Fluctuation of Fatigue in Multiple Sclerosis.

Authors:  Matthias Grothe; Stefan Gross; Marie Süße; Sebastian Strauss; Iris Katharina Penner
Journal:  Front Neurol       Date:  2022-06-17       Impact factor: 4.086

Review 7.  The pathophysiology of motor fatigue and fatigability in multiple sclerosis.

Authors:  Robert Patejdl; Uwe K Zettl
Journal:  Front Neurol       Date:  2022-07-27       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.